Arcturus Therapeutics’ mission is to harness the power of mRNA to develop life changing medicines and vaccines KPG Capital & CoMay 14, 2025
Anthos Therapeutics’ mission is to improve the lives of patients with cardiovascular KPG Capital & CoMay 14, 2025
Antibody Analytics’ mission is to unlock discoveries and develop solutions for biopharmaceutical companies KPG Capital & CoMay 14, 2025
Amolyt Pharma’s mission is to build and advance a portfolio of innovative therapies that address critical KPG Capital & CoMay 14, 2025
Amryt Pharma’s mission is to improve the lives of patients suffering from rare and serious conditions KPG Capital & CoMay 14, 2025
Andelyn Biosciences leverages decades of expertise in gene therapy research and manufacturing KPG Capital & CoMay 14, 2025
Angelini Pharma’s mission is to make a significant difference in patients’ lives by providing effective KPG Capital & CoMay 14, 2025
Amicus Therapeutics’ mission is to transform the lives of patients with rare and orphan diseases KPG Capital & CoMay 14, 2025
Advanced Health Limited’s mission is to enhance the quality of healthcare by offering efficient KPG Capital & CoMay 14, 2025
Atara Biotherapeutics focuses on several key therapeutic areas, with a primary emphasis on oncology KPG Capital & CoMay 14, 2025
AusBiotech provides a wide range of services and initiatives aimed at promoting the growth and development KPG Capital & CoMay 14, 2025
Avellino Lab offers a range of cutting edge technologies and services designed to advance the field of genetic KPG Capital & CoMay 14, 2025
Asher Biotherapeutics’ proprietary cistargeting platform is at the core of its therapeutic innovation KPG Capital & CoMay 14, 2025
Belite Bio’s lead candidate, LBS−008, is an oral therapy designed to reduce the accumulation of toxic vitamin A metabolites (A2E) KPG Capital & CoMay 14, 2025
At the core of Beam Therapeutics’ innovation is its proprietary base editing technology KPG Capital & CoMay 14, 2025
Bavarian Nordic is known for its innovative smallpox and monkeypox vaccine, IMVANEX® (also known as JYNNEOS® in the U.S. KPG Capital & CoMay 14, 2025
Bausch Health offers a comprehensive portfolio of prescription and over the counter eye care products KPG Capital & CoMay 14, 2025
Basilea is at the forefront of developing novel antibiotics to combat multidrug resistant bacterial infections KPG Capital & CoMay 14, 2025
Axonics Inc.’s flagship product is its proprietary SNM system, which includes several innovative features KPG Capital & CoMay 14, 2025
Avidity’s AOCs technology represents a novel approach to RNA therapeutics KPG Capital & CoMay 14, 2025
